High-Slice Computed Tomography Scanners Dominate Global Market

The global computed tomography (CT) market is experiencing significant growth, with a valuation of USD 6.3 billion in 2024 and an anticipated expansion to USD 11.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.0% during 2025–2032. This upward trajectory is primarily driven by the increasing applications of CT scanners across various medical procedures, including comprehensive imaging of the brain and body. Technological advancements and substantial government investments in countries such as India, China, and Japan are further propelling market growth.

Key Insights

Technological Advancements

Over the past decade, CT devices have seen significant technological developments, including the emergence of low-dose and automated CT scanners. These innovations offer superior image quality and enhanced spatial resolution with minimal radiation exposure. Notable advancements include iterative reconstruction technology, which provides better images at reduced radiation doses, and spectral imaging that utilizes dual energy sources for improved clarity.

Market Segmentation

·         By Type: High-slice CT scanners dominate the market, accounting for a 40% revenue share in 2024. Their superior diagnostic capabilities, such as producing clearer images with lower radiation doses, make them preferable for complex imaging procedures, including cardiovascular assessments.

·         By Application: The oncology segment leads the market, driven by increased cancer awareness and advancements in detection techniques. CT scans are extensively used to assess metastasis and provide high-clarity images vital for cancer diagnosis, staging, and treatment monitoring.

Regional Trends

·         North America: Holding a 40% revenue share in 2024, North America's dominance is attributed to the presence of key industry players and a high prevalence of chronic diseases. Continuous product innovations and a strong healthcare infrastructure further bolster the market in this region.

·         Asia-Pacific (APAC): APAC is projected to experience the highest CAGR of 8.5% during the forecast period. Factors such as the rising prevalence of cancer and cardiovascular diseases, coupled with growing healthcare investments in countries like China and India, contribute to this rapid growth.

Competitive Landscape

The CT market is fragmented, featuring a mix of established companies and emerging players. Key industry participants include GE HealthCare Technologies Inc., Siemens Healthineers, and Canon Inc., among others. These companies are actively engaging in product launches, strategic collaborations, and technological innovations to maintain a competitive edge.

In summary, the computed tomography market is poised for substantial growth, driven by technological advancements, expanding applications in medical diagnostics, and significant investments in healthcare infrastructure across various regions.

Read More

Gene Therapy: Why It Uses Viruses?

Human gene therapy aims to change a gene's expression or the biological makeup of live cells for therapeutic purposes. Gene therapy is a method for treating or curing disease by changing a person's DNA. Gene treatments can function in a variety of ways:

• Utilizing a healthy set of genes to replace a disease-causing gene

• A disease-causing gene that is malfunctioning can be turned off.

• The process of adding a new or altered gene to the organism to treat a condition

• Products utilizing gene therapy are being investigated to treat diseases such as cancer, genetic disorders, and infectious diseases.

Gene therapy is now a field that primarily exists in research labs, and its applicability is still being tested. Most trials occur in the U.S., Europe, and Australia. The therapy options are varied and might include viral infections, acquired genetic illnesses including cancer, and diseases brought on by recessive gene defects.

Recombinant DNA technology is one of the most frequently used techniques. In this method, a healthy gene or gene of interest is inserted into a vector, which can be nanostructured, plasmidial, or viral; the latter is most frequently used because it is most effective at invading cells and introducing its genetic material.

Get the sample pages of this report: https://bit.ly/3KPf9SH

What Is the Purpose of Gene Therapy?

Gene therapy aims to repair any harm brought on by any defective genes you may have. Gene therapy is ideally a means of treating or curing certain illnesses. Some people are born with faulty or missing genes. Some people have genes that evolve or alter with time.

New genes are introduced to replace or overcome the disease-causing, faulty genes already present in the body. Thus, the gene therapy market is predicted to grow in the coming years.

What Distinguishes In Vivo Gene Therapy from Ex Vivo Gene Therapy?

Ex-vivo gene therapy involves removing specific cells from the body and sending them to a lab. These cells are changed in the laboratory. A viral vector is frequently used to introduce fresh DNA into the cells. The freshly modified cells are then processed and returned to you, often by an intravenous infusion.

In-vivo gene therapy involves inserting fresh genetic material—typically DNA—directly into your cells. Typically, a vector delivers the novel genetic material straight to the target organ or by an injection into the blood. The in vivo gene therapy is expected to dominate the gene therapy market in the future.

Why Is Gene Therapy Delivered by Viruses?

A researcher may seek to utilize gene therapy to cure a genetic abnormality, and viruses offer a perfect method for delivering the therapy to the host cell. A virus is particularly successful at entering a cell because of its natural architecture.

Many viruses have had their whole genomes—the entire collection of genes that make up an organism—mapped or generated as blueprints by scientists. They can separate the viral genome's elements that are efficient at entering cells from the virus genome's potential pathogenic components. The gene therapy market is expected to increase faster in the virus category.

In addition, only a few harmless components of the original virus design are utilized, and these components are insufficient to spread a virus. Additionally, viral vectors are frequently used worldwide since they are more effective than non-viral alternatives. 

Read More